Mayo, Ashley J. http://orcid.org/0000-0001-8500-2256
Browne, Erica N.
Montgomery, Elizabeth T.
Torjesen, Kristine
Palanee-Phillips, Thesla
Jeenarain, Nitesha
Seyama, Linly
Woeber, Kubashni
Harkoo, Ishana
Reddy, Krishnaveni
Tembo, Tchangani
Mutero, Prisca
Tauya, Thelma
Chitukuta, Miria
Gati Mirembe, Brenda
Soto-Torres, Lydia
Brown, Elizabeth R.
Baeten, Jared M.
van der Straten, Ariane
Baeten, Jared
Palanee-Phillips, Thesla
Brown, Elizabeth
Soto-Torres, Lydia
Schwartz, Katie
Makanani, Bonus
Martinson, Francis
Bekker, Linda-Gail
Govender, Vaneshree
Siva, Samantha
Gaffoor, Zakir
Naidoo, Logashvari
Pather, Arendevi
Jeenarain, Nitesha
Nair, Gonasagrie
Matovu, Flavia
Mgodi, Nyaradzo
Mhlanga, Felix
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial
https://doi.org/10.1007/s10461-021-03205-z
Vaginal Ring Use in a Phase 3 Microbicide Trial: A Comparison of Objective Measures and Self-reports of Non-adherence in ASPIRE
https://doi.org/10.1007/s10461-018-2261-8
Experiences with simultaneous use of contraception and the vaginal ring for HIV prevention in sub-Saharan Africa
https://doi.org/10.1186/s12905-021-01321-5
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (UM1AI068633, UM1AI068615, UM1AI106707)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (UM1AI068633, UM1AI068615, UM1AI106707)
National Institute of Mental Health (UM1AI068633, UM1AI068615, UM1AI106707)
Article History
Accepted: 17 February 2021
First Online: 13 March 2021
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the following Institutional Review Boards/Ethics Committees and Drug Regulatory Authorities: Prevention Sciences Research Committee of the US National Institute of Allergy and Infectious Diseases; US Food and Drug Administration; National Health Sciences Research Committee of Malawi; Johns Hopkins University Bloomberg School of Public Health Institutional Review Board; University of North Carolina at Chapel Hill Institutional Review Board; Pharmacy, Medicines and Poisons Board of Malawi; University of Cape Town: Human Research Ethics Committee; Biomedical Research Ethics Committee University of KwaZulu-Natal; South African Medical Research Council Ethics Committee; Human Research Ethics Committee: (Medical), University of Witwatersrand, Johannesburg; Medicines Control Council of South Africa; Joint Clinical Research Centre Institutional Review Board; Uganda National Council for Science and Technology; Johns Hopkins University School of Medicine Institutional Review Board; National Drug Authority of Uganda; Medical Research Council of Zimbabwe; Committee on Human Research, University of California—San Francisco; Joint Parirenyatwa Hospital and College of Health Sciences Research Ethics; Research Council of Zimbabwe; Medicines Control Authority of Zimbabwe.
: Informed consent was obtained from all individual participants included in the study.